Literature DB >> 27402578

Lung cancer: Low-dose CT screening - determining the right interval.

David Yankelevitz1, Claudia Henschke1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27402578     DOI： 10.1038/nrclinonc.2016.106

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  5 in total

1.  Mammographic screening: no reliable supporting evidence?

Authors:  Olli S Miettinen; Claudia I Henschke; Mark W Pasmantier; James P Smith; Daniel M Libby; David F Yankelevitz
Journal:  Lancet       Date:  2002-02-02       Impact factor: 79.321

2.  Understanding the core result of the National Lung Screening Trial.

Authors:  David F Yankelevitz; James P Smith
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

3.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

4.  Lung cancers diagnosed at annual CT screening: volume doubling times.

Authors:  Claudia I Henschke; David F Yankelevitz; Rowena Yip; Anthony P Reeves; Ali Farooqi; Dongming Xu; James P Smith; Daniel M Libby; Mark W Pasmantier; Olli S Miettinen
Journal:  Radiology       Date:  2012-03-27       Impact factor: 11.105

5.  Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.

Authors:  Edward F Patz; Erin Greco; Constantine Gatsonis; Paul Pinsky; Barnett S Kramer; Denise R Aberle
Journal:  Lancet Oncol       Date:  2016-03-18       Impact factor: 41.316
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.